Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Asian Biomedicine
Volume 17 (2023): Numero 3 (June 2023)
Accesso libero
miR-30c-2-3p suppresses the proliferation of human renal cell carcinoma cells by targeting TOP2A
Xiaoyong Huang
Xiaoyong Huang
,
Yuna Jia
Yuna Jia
,
Haiyan Shi
Haiyan Shi
,
Haiyan Fan
Haiyan Fan
,
Lingbo Sun
Lingbo Sun
,
Huahua Zhang
Huahua Zhang
,
Yanfeng Wang
Yanfeng Wang
,
Jie Chen
Jie Chen
,
Jiaqi Han
Jiaqi Han
,
Mingming Wang
Mingming Wang
,
Juan Du
Juan Du
e
Jing Zhang
Jing Zhang
| 09 ott 2023
Asian Biomedicine
Volume 17 (2023): Numero 3 (June 2023)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Articolo
Immagini e tabelle
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Article Category:
Original article
Pubblicato online:
09 ott 2023
Pagine:
124 - 135
DOI:
https://doi.org/10.2478/abm-2023-0052
Parole chiave
apoptosis
,
miR-30c-2-3p
,
renal cell carcinoma
,
TOP2A
,
treatment
© 2023 Xiaoyong Huang et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Xiaoyong Huang
Department of Clinical Medicine, Medical College of Yan’an University
Yan’an, China
Yuna Jia
Department of Clinical Medicine, Medical College of Yan’an University
Yan’an, China
Haiyan Shi
Department of Clinical Medicine, Medical College of Yan’an University
Yan’an, China
Haiyan Fan
Department of Laboratory, The First Hospital of Yulin
Yulin, China
Lingbo Sun
Department of Clinical Medicine, Medical College of Yan’an University
Yan’an, China
Huahua Zhang
Department of Clinical Medicine, Medical College of Yan’an University
Yan’an, China
Yanfeng Wang
Yan’an, China
Jie Chen
Department of Clinical Medicine, Medical College of Yan’an University
Yan’an, China
Jiaqi Han
Department of Clinical Medicine, Medical College of Yan’an University
Yan’an, China
Mingming Wang
Department of Clinical Medicine, Medical College of Yan’an University
Yan’an, China
Juan Du
Department of Clinical Medicine, Medical College of Yan’an University
Yan’an, China
Jing Zhang
Department of Clinical Medicine, Medical College of Yan’an University
Yan’an, China
Yan’an Key Laboratory of Chronic Disease Prevention and Research
Yan’an, China